Drug Topics October 27, 2024
Lauren Biscaldi, MS, Managing Editor

PBM reform legislation has progressed further in Congress than ever before.

Cole Schmidtknect was only 22 years old when he died.

In January, Cole—who had been diagnosed with severe asthma at age 1—went to the pharmacy to pick up the inhaler he used to manage his condition. There, he learned that his inhaler was no longer covered by his insurance; there was no alternative, and no generic option.

Five days later, Cole had a severe asthma attack. He went into cardiac arrest on the way to the hospital, spent 6 days in the intensive care unit, and died on January 21, 2024.

At the 2024 National Community Pharmacists Association (NCPA) Annual Convention and Expo,1 Cole’s father Bil Schmidtknect shared his...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers

Share This Article